6 recruiting. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Recruiting 6 |
Follow Insomnia: new trials by email Literature Review of Insomnia trials Research Report on Insomnia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia Sleep Hygiene Education, Melatonin IR, 3 mg, Melatonin IR, 5 mg - Insomnia, Insomnia Disorder | Phase 4 | Recruiting | University of Pennsylvania | 1200 | 2026-05-01 | 2026-09-16 |
| Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms Cognitive behavioral therapy for insomnia (CBT-i), Trazodone, Daridorexant - Menopausal Women, Insomnia | Phase 4 | Recruiting | Brigham and Women's Hospital | 1000 | 2026-02-13 | 2026-06-08 |
| No More Sleepless Nights in Perimenopause Cognitive Behavioural Therapy for Insomnia (CBT-I), Hormone Replacement Therapy (HRT), Sleep Hygiene - Insomnia, Menopause | Phase 4 | Recruiting | Insel Gruppe AG, University Hospital Bern | 54 | 2026-01-01 | 2026-01-13 |
| Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN) Eszopiclone 3 mg, Placebo - Insomnia, Hypertension | Phase 4 | Recruiting | University of Sao Paulo | 150 | 2025-06-04 | 2025-06-12 |
| Enhancing Hypnotic Medication Discontinuation in Primary Care Digital Cognitive Behavioral Therapy, Structured Medication Tapering - Insomnia, Hypnotic Dependence | Phase 4 | Recruiting | National Jewish Health | 430 | 2025-01-01 | 2026-01-23 |
| Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial Lemborexant 5 MG - Insomnia, Dementia | Phase 4 | Recruiting | Nova Scotia Health Authority | 1 | 2023-12-11 | 2025-02-21 |
Sleep Initiation and Maintenance Disorders (6) · Dementia (1) · Frontotemporal Dementia (1) · Hypertension (1)
Dyssomnias (6) · Mental Disorders (6) · Nervous System Diseases (6) · Sleep Disorders, Intrinsic (6) · Sleep Wake Disorders (6) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Frontotemporal Lobar Degeneration (1) · Metabolic Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Nutritional and Metabolic Diseases (1) · Proteostasis Deficiencies (1) · TDP-43 Proteinopathies (1)
Cognitive Behavioral Therapy (2) · Trazodone (2) · Diphenhydramine (1) · Doxepin (1) · Eszopiclone (1) · Hormone Replacement Therapy (1) · Zolpidem (1) · daridorexant (1) · lemborexant (1)
Brigham and Women's Hospital (1) · Insel Gruppe AG, University Hospital Bern (1) · National Jewish Health (1) · Nova Scotia Health Authority (1) · University of Pennsylvania (1) · University of Sao Paulo (1)
United States (3) · Brazil (1) · Canada (1) · Switzerland (1)
Luciano F. Drager, MD, PhD (1) · Michael L Perlis, PhD (1) · Petra Stute, Prof. (1) · Suzanne Bertisch, MD, MPH (1)
2023 (1)